Related Experiment Videos
Arrhythmias associated with Chagas' heart disease
1Division of Cardiology, Ramos Mejía Hospital, Buenos Aires, Argentina. cardiorm@gema.org.ar
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Argentina's most important contributions in the field of electrophysiology.
Heart rhythm O2·2024
Ventricular Parasystole in Cardiomyopathy Patients: A Link Between His-Purkinje System Damage and Ventricular Fibrillation.
JACC. Clinical electrophysiology·2023
Fascicular Blocks: Update 2019.
Current cardiology reviews·2020
Second-degree interatrial block: Brief review and concept.
Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc·2018
Cardiac automaticity: basic concepts and clinical observations.
Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing·2018
Cost-effectiveness of the implantable cardioverter defibrillator.
Cardiac electrophysiology review·2004
The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
Cardiac electrophysiology review·2004
DEFibrillators In Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE).
Cardiac electrophysiology review·2004
Amiodarone versus Implantable Defibrillator (AMIOVIRT): background, rationale, design, methods, results and implications.
Cardiac electrophysiology review·2004
Fractional exhaled nitric oxide is a non-invasive disease activity marker of IgG4-related disease.
Rheumatology (Oxford, England)·2026
Coronary CT angiography-derived perivascular fat attenuation index as a potential marker for heart failure in hypertrophic cardiomyopathy.
The British journal of radiology·2026
One-Step Immobilized Phage Depolymerase Coatings for Catheter-Related Bloodstream Infections.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Inhibition of Dyrk1a attenuates type 1 diabetic cardiomyopathy via anti‑ferroptosis.
Molecular medicine reports·2026